Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-25-003178
Filing Date
2025-05-14
Accepted
2025-05-14 15:55:11
Documents
45
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q xbit20250331_10q.htm   iXBRL 10-Q 525864
2 EXHIBIT 31.1 ex_810826.htm EX-31.1 11854
3 EXHIBIT 31.2 ex_810827.htm EX-31.2 11824
4 EXHIBIT 32.1 ex_810828.htm EX-32.1 7021
  Complete submission text file 0001171843-25-003178.txt   2989273

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA xbit-20250331.xsd EX-101.SCH 25651
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xbit-20250331_def.xml EX-101.DEF 191704
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE xbit-20250331_lab.xml EX-101.LAB 188671
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xbit-20250331_pre.xml EX-101.PRE 216434
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xbit-20250331_cal.xml EX-101.CAL 22287
48 EXTRACTED XBRL INSTANCE DOCUMENT xbit20250331_10q_htm.xml XML 311465
Mailing Address 5217 WINNEBAGO LANE AUSTIN TX 78744
Business Address 5217 WINNEBAGO LANE AUSTIN TX 78744 512-386-2900
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37347 | Film No.: 25945015
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)